Prevention

A new study challenges common misconceptions associated with cases of non-ventilator hospital-acquired pneumonia, emphasizing the need for a broader use of preventive measures.

Dr. Richard Vickers, explains how ridinilazole is unique in its spectrum of activity compared with other antibiotics that target C. diff and have been approved or are in development.

Health officials across the United States have their hands full as hepatitis A cases continue to spring up.

Richard Haupt, MD, MPH, discusses what would be required to adequately implement the delivery of a future C. diff vaccine.

Rates of re-hospitalization and long-term health effects remain high among sepsis survivors, which is why researchers are outlining ways to help sepsis patients after hospital discharge.

The CDC releases first comprehensive reports on state progress made in the fight against antibiotic resistance since Congress’ investment in CDC’s Antibiotic Resistance Solutions Initiative.

The FDA releases notice on how to keep hospital mattresses and mattress covers safe to prevent the spread of deadly bugs throughout health care facilities.

Most of the United States is now seeing widespread flu activity, as health officials urge flu sufferers to receive antiviral treatment as soon as possible.

Barley Chironda, RPN, CIC, explains what the “chain of infection” is and what is needed to break it.

A recent study suggests that the new antibiotic combination ceftazidime-avibactam may be a useful alternative for treating hospital-acquired pneumonia.

Contagion® interviews Tetraphase’s CEO Guy Macdonald about eravacycline, an investigational drug candidate for the treatment of complicated intra-abdominal infections.

Leonard Sigal, MD, explains the potential adverse consequences of long-term antibiotic therapy.

The development of mold-active azoles has led to enormous advancements in both prevention and treatment of invasive fungal infections.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

William Schaffner, MD explains why pregnant women should get vaccinated against flu.

The estimated global burden of the disease ranges from 11 to 20 million cases and contributes to about 128,000 to 161,000 deaths each year.

At the 5th annual international C. diff Awareness Conference and Health Expo, Dr. Edmond Hooker discussed an underreported problem in health care facilities everywhere.

With 13 more states reporting widespread flu activity in week 51, flu season continued to ramp up in the final weeks of 2017.

Could 2018 finally be the year polio is eliminated as a global health concern?

Achaogen reports “positive top-line results” from phase 1 trial of orally-administered antibacterial candidate C-scape.

The CDC has issued a travel watch due to measles outbreaks in England and Greece.

Intra-abdominal infections (IAIs) are defined as disease processes occurring in normally-sterile parts of the abdominal cavity, and are generally treated mechanically, such as by surgery.

Saskia Popescu, MPH, MA, CIC, breaks down why an unlikely presence at the BWC highlights the growing importance of civil society involvement in global health safety and security.

The device, from Sanuwave Health, was previously approved outside of the United States for advanced wound care indications.

Richard Haupt, MD, MPH, sheds light on the Clostridium difficile Vaccine Efficacy Trial (CLOVER).

Daniel Diekema, MD, explains how clinicians can actively work to prevent pathogen spread in their health care facilities.

Check out the top 10 infectious disease articles of 2017.

Leonard Sigal, MD, explains why Lyme disease is sometimes overdiagnosed or overtreated.

A recent webinar hosted by the Centers for Disease Control and Prevention and nursing organizations highlighted the important role of nurses in implementing hospital antibiotic stewardship programs.

The only way individuals can reduce their risk of getting shingles is to get vaccinated; luckily, a new vaccine has recently been approved by the FDA.